Khiron Life Sciences Corp.

  • instagram
  • LinkedIn
language
English Español Português Deutsch

A GLOBAL MEDICAL CANNABIS COMPANY

IMPROVING THE QUALITY OF PEOPLES' LIVES

TSXV: KHRN | OTCQX: KHRNF | FRANKFURT: A2JMXC

6
Countries:
 SELLING IN COLOMBIA, PERU, GERMANY, UK, BRAZIL AND TARGETING MEXICO FOR 2022
>50,000
Medical cannabis prescriptions filled year-to-date
>50%
MEDICAL CANNABIS REVENUES GENERATED IN EUROPE IN Q1 2022
>70%
Gross margin on medical cannabis sales in 2021
>60%
Retention Rate AT KHIRON'S ZERENIA CLINIC PATIENTS GLOBALLY
>80%
MEDICAL CANNABIS SALES THROUGH INSURANCE IN COLOMBIA

RTVC - Zerenia signed with CAPITAL SALUD EPS, Colombia´s largest Public Insurance Company

ARRIBA BOGOTÁ - Zerenia will provide integrative health services and medical cannabis

NOTICIAS 1 - CAPITAL SALUD EPS has already begun treating the first cohort of patients

AWT $KHRNF Khiron Life Sciences Update Alvaro Torres CEO

Khiron at Benzinga Cannabis Insider

Patients Stories

AWT Mystery Interview #10 Reveal $KHRNF Khiron Life Sciences CEO Alvaro F Torres Co-Founder & CEO

Vicente Fox on BNN Bloomberg

CannaWeek: Ep 73 - Alvaro Torres, Khiron Life Sciences

OUR
BUSINESS UNITS

khiron
Health Services
khiron
Med

GLOBAL
EXPANSION

Khiron is well-positioned to take advantage of the emerging global cannabis opportunity.

Leadership

KHIRON LIFE SCIENCES is led by a multidisciplinary and multicultural team with a unique understanding of various industries across Latin America and Europe

View Management Team View Board of Directors

Investor
Contact

T: 1 (647) 556-5750
investors@khiron.ca

Have a business-related question about KHRN? Or just general inquiries? Send us a message and we'll be happy to help.

Contact Us